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Abstract
Background: The aim of our study was to investigate and control an outbreak and identify risk factors for
colonization and infection with Serratia marcescens in two departments in Tartu University Hospital.
Methods: The retrospective case–control study was conducted from July 2005 to December 2006. Molecular typing
by pulsed field gel electrophoresis was used to confirm the relatedness of Serratia marcescens strains. Samples from
the environment and from the hands of personnel were cultured.
Results: The outbreak involved 210 patients, 61 (29%) developed an infection, among them 16 were invasive
infections. Multivariate analysis identified gestational age, arterial catheter use and antibiotic treatment as
independent risk factors for colonization and infection with Serratia marcescens. Molecular typing was performed on
83 Serratia marcescens strains, 81 of them were identical and 2 strains were different.
Conclusions: Given the occasionally severe consequences of Serratia marcescens in infants, early implementation of
aggressive infection control measures involving patients and mothers as well as the personnel is of utmost
importance.
Background
Neonates admitted to neonatal intensive care units
(NICUs) are at high risk of nosocomial infection (NI) [1-3].
NIs due to gram-negative rods are usually caused by
bacterial strains that have already colonized the infants
[4]. Most neonates acquire Enterobacteriaceae, primarily
different strains of Klebsiella sp, E. coli and Enterobacter
sp. Serratia sp. is a gram-negative rod-shaped bacterium
that may colonize the nasopharynx and the gut and oc-
casionally causes invasive (bloodstream infection, men-
ingitis, pneumonia) and noninvasive (urinary tract,
conjunctivitis) infections in neonates. During the last
decade several articles have been published about out-
breaks caused by Serratia sp., especially in neonatal in-
tensive care units [5-9]. Independent risk factors for
colonization and infection with Serratia sp. are not well
established, but low birth weight, prematurity, pro-
longed hospital stay, antibiotic use and mother’s infec-
tions prior to delivery have been found to be risk factors
according to some investigators [5,6,9,10]. The aim of
our study was to describe the outbreak and identify risk
factors for colonization and infection with Serratia
marcescens in the Pediatric Intensive Care Unit (PICU)
and the Neonatal Unit (NU) in Tartu University Hospital
from July 2005 to December 2009.
Methods
Setting
Tartu University Hospital is a 960-bed tertiary care
teaching hospital with approximately 43 000 admissions
annually. The study was conducted in two units: a 9-bed
PICU and a 24-bed NU, which serve 300 and 800 admis-
sions per year, respectively. Approximately 2/3 of PICU
patients are neonates and 1/3 older children. Neonates,
who no longer require intensive care are transferred to
NU on the same floor. If the condition should worsen,
neonates can be transferred back to PICU.
Neonatologists and trained neonatal nurses work in
the units. The nurse to patient ratio is usually up to 1:2
in PICU, in NU there is a separate nurse for patients re-
quiring intermediate care (6 beds) and two nurses for
the other patients.
The antibiotic policy at the time of our study recom-
mended benzylpenicillin/ampicillin and gentamicin as
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the first-line empirical treatment for suspected early-
onset sepsis. This study was approved by Research Eth-
ics Committee of the University of Tartu (UT REC),
215/T-8.
Microbiological methods
In order to investigate the outbreak samples for surveil-
lance, cultures were obtained from nares and rectum of
all patients on admission and twice a week as part of
standard care in both units. Nasal and rectal swabs were
plated on agar (DNAase Agar Test Agar with Methyl
Green, Becton Dickinson, USA) selective for Serratia
species.
Isolates of Serratia marcescens from clinical or screen-
ing specimens were identified by using the identification
method routinely employed in our clinical microbiology
laboratory and verified by biochemical identification sys-
tem VITEK2 Compact (BioMerieux, France) using GN
card. Antimicrobial susceptibility was determined
according to the recommendations of the Clinical and
Laboratory Standards Institute [11]. All isolates were
stored at −80°C for future analysis.
Environmental cultures were obtained from potential
sources such as sinks, soaps, different surfaces (incuba-
tors, perfusors), medical equipment (oxygen tubes, oxy-
gen masks, feeding syringes, breast pumps) and
opened vials and bottles (antibiotics, saline and glucose
solutions). In addition, hands of the personnel were
cultured twice. Pre moistened swabs (APTACA, Amies
transport medium, Italy) were used for obtaining cul-
tures from the environment as well as from the hands
of health care workers. The specimens were plated and
evaluated in the same manner as the patients’ surveil-
lance cultures.
Typing
Molecular analysis of each isolate was performed by
pulsed field gel electrophoresis (PFGE). DNA plugs were
prepared by following manufacturer’s instructions for
the GenePath Group 3 Reagent kit (Bio-Rad Laborator-
ies, Hercules, CA, USA). After restriction enzyme diges-
tion with 25 U of SpeI, gels were electrophoresed for 22 h
at 14°C at a constant voltage 6V/cm using the CHEF-DR
III system (Bio-Rad). Isolates were considered to be the
same genotype using the criteria described by Tenover
et al [12].
Case–control study
To identify risk factors for colonization or infection with
Serratia marcescens we conducted retrospective case–
control study among patients hospitalized from July
2005 to December 2006 (Figure 1).
A case was defined as a neonate, who was admitted to
PICU or NU during the period from July 2005 to December
2006 with at least one clinical or surveillance culture posi-
tive for Serratia marcescens. Neonates whose cultures
remained negative for Serratia marcescens served as con-
trols. Children older than 28 days were not included in the
case–control study.
Colonization was defined as a positive culture for Serratia
marcescens in the absence of infection symptoms. Infection
was defined as presence of infection symptoms simultan-
eously with isolation of Serratia marcescens from a clinical
specimen.
Risk factors were evaluated retrospectively from medical
records including demographic characteristics, gestational
age, birth weight, Apgar scores, duration of mechanical
ventilation, exposure to indwelling devices, nutrition (par-
enteral and enteral feeding), surgery and antimicrobial
Figure 1 Epidmic curve for an outbreak with Serratia marcescens in Tartu University Hospital. (white box - colonization, black box -
infection in unit A, gray box - infection in unit B, I - invasive infection).
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therapy. Finally, risk factors for colonization and infection
were analyzed separately.
Statistical analysis
Logistic regression analysis was used to calculate odd
ratios and 95% confidence limits to describe differences
in risk factors. Significant factors from univariate ana-
lysis were used to perform multivariate analysis. Statis-
tical significance was set at p<0.05.
The statistical analyses of the data were performed




The outbreak investigation was conducted in two
departments after Serratia marcescens was isolated from
blood cultures of three patients in short intervals. The
retrospective analysis of the microbiology laboratory
database showed that Serratia marcescens colonization
or infection had not been detected in neither of the
departments during two previous years (2003 and 2004).
From July 2005 to December 2009 a total of 210
patients with Serratia marcescens colonization or infec-
tion were identified. At the end of 2006 and in the be-
ginning of 2007 the number of cases reached the
maximum and began to decrease in 2008.
In 2010 there have been no cases. The distribution of
cases by months and exact numbers per 1000 bed days
are presented on an epidemic curve (Figure 1).
Out of 210 patients 111 (53%) were males and 99
(47%) females. Most of them (n=181) were neonates, 27
children were under the age of 1 year and 2 children
were older than 1 year. Among all neonates (n=181) 27
(15%) were born at term and 154 (85%) were preterm
(birth before 37 weeks of gestation). Among preterm
neonates 67 had a birth weight <1500 g and 22 weighed
<1000 g.
Out of 210 patients 61 (29%) developed an infection:
16 of these were invasive infections (bloodstream infec-
tion, meningitis). 149 of these patients were colonized,
most of them at more than one site.
The mean length of stay in PICU until the first posi-
tive culture was 12.4 (range 1 to 64) days and in NU
11.8 (range 1 to 74) days.
Case–control Study
The case–control study included 105 case-patients and
206 control-patients. Risk factors associated with acquisi-
tion of Serratia marcescens in univariate analysis are pre-
sented in Table 1. Multivariate analysis with logistic
regression was performed to control confounding vari-
ables. Multivariate analysis identified gestational age, arter-
ial catheter use and antibiotic treatment as independent
risk factors for colonization and infection with Serratia
marcescens (Table 2).
The analysis of risk factors for colonization and infec-
tion separately showed that statistically significantly
more arterial catheters had been used in infected
patients (OR 1.67 CI95% 1.16 – 2.4).
Genotyping and Antibiotic Susceptibility
Molecular typing was performed on 83 Serratia marcescens
strains, 81 of them were identical (clone A, Figure 2) and 2
strains were different (clone B). All isolates were in vitro
susceptible to cefotaxime, cefepime, piperacillin/tazobac-
tam, meropenem, imipenem, gentamicin, amikacin and
ciprofloxacin. All isolates were resistant to ampicillin,
ampicillin/sulbactam and cefuroxime.
Infection control measures
All cultures (n= 189) obtained from inanimate surfaces in
the wards were negative for Serratia marcescens with the
exception of the 0.9% NaCl syringe, which was used for a
child, who had been previously colonized with Serratia
marcescens.
None of the cultures obtained from personnel hands
yielded Serratia marcescens.
Attempts were made to separate infected neonates from
non-infected neonates. Cohorting the personnel turned
out to be a problem due to the lack of health care workers.
In order to improve the availability of hand antiseptics,
dispensers of hand antiseptics were placed at all incuba-
tors. The personnel was educated to revise the rules of
hand hygiene and attention was paid to the compliance
with hand hygiene recommendations. The usage of hand
antiseptics was calculated on the basis of pharmacy’s
database.
According to the recommendations of the infection
contol team, disposable feeding syringes were taken into
use and breast pumps were made available in every pa-
tient room in the NU. The algorithm of cleaning the
breast pumps was also intensified. The ward was sup-
plied with an instrument washing machine.
Discussion and conclusion
Serratia sp., formerly considered to be a benign com-
mensal only, is now recognized as an important cause of
outbreaks, especially in neonatal intensive care units
16,22. According to our knowledge this is the largest
published outbreak in terms of case numbers and
duration.
Our study showed that gestational age, antimicrobial
therapy and arterial lines are significantly associated with
colonization and infection with Serratia marcescens.
The development of the intestinal microflora starts at
birth and is influenced by various factors such as
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gestational age, mode of delivery, local environment,
type of feeding and antibiotic treatment [13,14].
The role of antibiotics as a risk factor has been investi-
gated in several similar case–control studies [5,6,9,10].
Statistically significant associations between previous
antibiotic treatment of mothers [5,6] and neonates [10]
have been found by some authors. It is known that
antibiotic treatment may affect the colonization with
gram-negative bacteria. Antibiotic therapy suppresses
formation of normal flora, reduces remarkably colo-
nization resistance and increases risk of acquiring a
nosocomial strain [4]. It is difficult to estimate to what
extent antibiotic treatment influenced our outbreak. We
suppose that our empirical antibiotic treatment didn`t
influence the acquisition of Serratia significantly, the
major factor was rather the poor compliance to infection
control measures. We did not change the guidelines of
empirical antibacterial treatment at a time of the out-
break, because in similar studies its significance in
terminating the outbreak has remained unclear [16].
The second finding was the presence of an arterial line
as an independent risk factor for colonization and infec-
tion with Serratia marcescens. Other studies have also
shown invasive intravascular devices as risk factors for
colonization and infection with Serratia sp. [5,17,18].
However, Maragakis et al. [17] suppose that these are ra-
ther markers of severity of illness and susceptibility of a
Table 2 Multivariate analysis of factors associated with
Serratia marcescens colonization or infection
Variable OR CI95%
Gestational age 0,82 0,75–0,91
Arterial catheter 4,49 1,57–12,82
Antimicrobial therapy 6,01 2,42–14,96
Note. - OR odds ratio, CI95 95% confidence interval.
Table 1 Univariate anaysis of risk factors associated with Serratia marcescens infection or colonzation
Characteristic Case patients (n= 105) Control patients (n= 206) OR CI95
Mean gestational age, wk 34 37 0,76* 0,69–0,83
(range; OR per week) (23–41) (25–42)
Mean birth weight, g 2235 2986
(range; OR per 500g) (500–5220) (400–5850) 0,56* 0.6–0.68
Vaginal delivery 50 (48%) 132 (64%)
Cesarean section 55 (52%) 74 (36%) 1,92* 1.18–3.12
Apgar score after 1 min 6 7 0,84* 0.75–0.93
Prematurity 75 (71%) 74(36%) 5.46* 3.01–9.93
Invasive device
Intubation 35 (33%) 27 (13%) 2,18* 1,55–8,43
Mean duration of intubation, d 8,1 3,7
(range) (1–61) (1–24) 1,06 0,93–1,22
CVC 31 (30%) 31 (15%) 2,87* 1,51–5,46
Mean duration of CVC,d 10 7,4
(range) (1–42) (1–30) 1,08* 1,02–1,13
Arterial catheter 51 (49%) 45 (22%) 10,44* 4,06–26,83
Peripherial catheter 102 (97%) 160 (78%) 10,18* 3,09–33,53
Nasogastral tube 86 (82%) 88 (43%) 6,86* 3,57–10,07
Parenteral feeding 28 (27%) 25 (12%) 4,72* 2,27–9,8
Breast milk 77 (73%) 179 (87%) 0,37* 0,19–0,71
Antimicrobial therapy 93 (89%) 100 (51%) 10,86* 4,63–25,46
Mean duration of antimicrobial therapy, d 7,5 6,5 1,03 0,98–1,08
(range) (1–52) (1–29)
Maternal infection 21 (20%) 45 (24%) 0,84 0,46–1,53
Mean length of stay, d 31 13 1,05* 1,03–1,07
(range) (3–213) (2–90)
Surgery 14 (13%) 11 (5%) 2,72* 1,16–6,37
Outcome (death) 4 (4%) 3 (2%) 3,61 0,65–19,91
Note. Time-dependent risk factors have been evaluated until the first positive culture for Serratia marcescens.
OR odds ratio, CI95 95% confidence interval.
*statistical significance (p< 0.05).
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patient to infection than independent risk factors. We
also agree with this statement and presume that the
usage of these devices has probably no direct causal role
in colonization with Serratia marcescens. On the other
hand, invasive device use increases the number of con-
tacts with personnel and thus, in case of suboptimal
hand hygiene, increases the possibility of transmission.
In order to improve insertion and care of intravascular
catheters, including arterial catheters, a guideline was
drawn up and implemented.
As in most of the other outbreak studies, the reservoir
and mode of transmission remained unknown also in
our study. We suppose that asymptomatic patients are
the most important reservoir of Serratia sp., because
after the implementation of screening policy (included
samples from nasopharynx and rectum) and isolation
precautions the number of new cases decreased signifi-
cantly. As in our study the gastrointestinal tracts as well
as respiratory tracts of neonates were frequently colo-
nized, we agree with Giles et al. [19] that during Serratia
sp. outbreak both respiratory and gastrointestinal sam-
ples should be collected in order to maximize the identi-
fication of colonized infants.
There is a likelihood that the organisms may have
been transmitted via the hands of health care workers
and mothers. This hypothesis is supported by the evi-
dence that no other cultures taken from the environ-
ment were positive. However, cultures taken from the
hands of health care workers were negative. In 2001–
2003 a study conducted in New York Presbyterian
Hospital in New York City aimed to determine the
relative frequency of potential horizontal transmission
between patients and health care workers in the NICU.
This large prospective study indicated a potentially
higher probability of cross-transmission with certain
gram-negative bacilli, such as Klebsiella pneumoniae and
Serratia marcescens via the hands of health care workers
[20]. We speculate that in addition to personnel,
mothers may have had a role in transmission of Serratia
sp. in the ward. Hand hygiene rules were explained to
mothers, but their compliance was not followed rou-
tinely. Unfortunately no samples were cultured from
mothers’ hands during the outbreak.
Closing the ward temporarily has been an efficient
measure to terminate an outbreak [6,21]. This option
was under discussion in our case, but it was not possible
to transfer intensive care patients to another hospital
(due to long distance) or to open an additional ward
(lack of qualified personnel). It was also impossible to
employ additional personnel.
Limitation of our study concerns the aspect that
among control patients there could be patients colonized
with other bacteria due to the fact that a selective cul-
ture for Serratia sp. was used for screening. It is possible
that previous colonization with other gram-negative bac-
teria causes colonization resistance of the gastrointes-
tinal tract and reduces the opportunity to colonize with
potentially pathogenic microorganisms such as Serratia
marcescens. On the other hand, as the length of stay in
PICU was 12.4 days till the first positive culture and in
NU 11.8 days, there is a possibility that case-patients
were colonized with other gram-negative bacteria also
by that time.
In conclusion, we can say that as the implementation
of infection control measures was delayed, the outbreak
lasted a long time. In order to terminate an outbreak
caused by Serratia sp. promptly, early implementation of
thoroughly considered aggressive infection control mea-
sures involving patients and mothers as well as the
personnel is of utmost importance. Continued attention
should be paid on optimizing antibiotic usage.
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Figure 2 Pulsed field gel electrophoresis of Serratia marcescens strains isolated from infected or colonized patients and environment.
M - lambda marker; lane 1 - environmental culture; lane 2–17 strains from infected or colonized patients.
Adamson et al. BMC Infectious Diseases 2012, 12:281 Page 5 of 6
http://www.biomedcentral.com/1471-2334/12/281
Authors’ contributions
VA planned the study, carried out the data collection and analysis,
performed PFGE of all collected strains and drafted the manuscript. HP
participated in the design of the study and performed statistical analysis. PM
participated in the design of the study and data analysis and drafted the
manuscrip. TM participated in coordination of the study and helped to draft
the manuscript. KT participated in the data collection and helped to carry
out the molecular studies PN helped to plan and design the study,
participated in coordination in the field of microbiology and drafted the
manuscript. MM conceived the study and participated in its design and
coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgments
This study was funded by the Ministry of Education and Research of Estonia
(targeted financing SF0180081s07).
Author details
1Department of Infection Control, Tartu University Hospital, Puusepa 1a,
50406, Tartu, Estonia. 2Department of Public Health, University of Tartu, Tartu,
Estonia. 3Pediatric Intensive Care Unit, Intensive Care Clinic, Tartu University
Hospital, Tartu, Estonia. 4Department of Medical Microbiology, Stavanger
University Hospital, Stavanger, Norway. 5Department of Internal Medicine,
Tartu University Hospital, Tartu, Estonia.
Received: 22 September 2011 Accepted: 23 October 2012
Published: 31 October 2012
References
1. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in
pediatric intensive care units in the United States. National Nosocomial
Infections Surveillance System. Pediatrics 1999, 103:e39.
2. Raymond J, Aujard Y, the European Study Group: Nosocomial infections in
pediatric patients: a European, multicenter prospective study. Infect
Control Hosp Epidemiol 2000, 21:260–263.
3. Brady MT: Health care-associated infections in the neonatal intensive
care unit. Am J Infect Control 2005, 33:268–275.
4. Almuneef MA, Baltimore RS, Farrel PA, Reagan-Cirincione P, Dembry LM:
Molecular typing demonstrating transmission of gram-negative rods in a
neonatal intensive care unit in the absence of a recognized epidemic.
Clin Infect Dis 2001, 32:220–227.
5. Sarvikivi E, Lyytikäinen O, Salmenlinna S, et al: Clustering of Serratia
marcescens infections in a neonatal intensive care unit. Infect Control
Hosp Epidemiol 2004, 25:723–729.
6. Assadian O, Berger A, Aspöck C, Mustafa S, Kohlhauser C, Hirschl A:
Nosocomial outbreak of Serratia marcescens in a neonatal intensive care
unit. Infect Control Hosp Epidemiol 2002, 23:457–461.
7. Lai KK, Baker SP, Fontecchio SA: Rapid eradication of a cluster of Serratia
marcescens in a neonatal intensive care unit: use of epidemiologic
chromosome profiling by pulsed-field gel electrophoresis. Infect Control
Hosp Epidemiol 2004, 25:730–734.
8. Fleisch F, Zimmermann-Baer U, Zbinden R, et al: Three consecutive
outbreaks of Serratia marcescens in a neonatal intensive care unit.
Clin Infect Dis 2002, 34:767–773.
9. Friedman ND, Kotsanas D, Brett J, Billah B, Korman TM: Investigation of an
outbreak of Serratia marcescens in a neonatal unit via a case–control
study and molecular typing. Am J Infect Control 2008, 36:22–28.
10. Crivaro V, Bagattini M, Salza MF, et al: Risk factors for extended-spectrum
ß-lactamase-producing Serratia marcescens and Klebsiella pneumoniae
acquisition in a neonatal intensive care unit. J Hosp Infect 2007,
67:135–141.
11. Clinical and Laboratory Standards Institute: Performance Standards for
Antimicrobial Susceptibility Testing. 16th Informational Supplement. 2006.
12. Tenover FC, Arbeit RD, Goering RV, et al: Interpreting chromosomal DNA
restriction patterns produced by pulsed-field gel electrophoresis: criteria
for bacterial strain typing. J Clin Microbiol 1995, 33:2233–2239.
13. Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg
RM: The intestinal bacterial colonisation in preterm infants: A review of
the literature. Clin Nutr 2006, 25:361–368.
14. Toltzis P, Dul MJ, Hoyen C, et al: Molecular epidemiology of antibiotic-
resistant gram-negative bacilli in a neonatal intensive care unit during a
nonoutbreak period. Pediatrics 2001, 108:1143–1148.
15. Manning ML, Archibald LK, Bell LM, Banerjee SN, Jarvis WR: Serratia
marcescens transmission in a pediatric intensive care unit: a
multifactorial occurrence. Am J Infect Control 2001, 29:115–119.
16. Voelz A, Müller A, Gillen J, et al: Outbreaks of Serratia marcescens in
neonatal and pediatric intensive care units: clinical aspects, risk factors
and management. Int J Hyg Environ Health 2010, 213:79–87.
17. Maragakis LL, Winkler A, Tucker MG, et al: Outbreak of multidrug-resistant
Serratia marcescens infection in a neonatal intensive care unit. Infect
Control Hosp Epidemiol 2008, 29:418–423.
18. Buffet-Bataillon S, Rabier V, Bétrémieux P, et al: Outbreak of Serratia
marcescens in a neonatal intensive care unit: contaminated unmedicated
liquid soap and risk factors. J Hosp Infect 2009, 72:17–22.
19. Giles M, Harwood HM, Gosling DA, Hennessy D, Pearce CT, Daley AJ: What
is the best screening method to detect Serratia marcescens colonization
during an outbreak in a neonatal intensive care nursery? J Hosp Infect
2006, 62:349–352.
20. Waters V, Larson E, Wu F, et al: Molecular epidemiology of gram-negative
bacilli from infected neonates and health care workers’hands in
neonatal intensive care units. Clin Infect Dis 2004, 38:1682–1687.
21. van Ogtrop ML, van Zoeren-Grobben D, Verbakel-Salomons EM, van Boven
CP: Serratia marcescens infections in neonatal departments: description
of an outbreak and review of the literature. J Hosp Infect 1997, 36:95–103.
22. Gastmeier P, Loui A, Stamm- balderjahn s et al. Outbreaks in neonatal
intensive care units- They are not like others. Am J Infect Control 2007,
35:172–6.
doi:10.1186/1471-2334-12-281
Cite this article as: Adamson et al.: Prolonged outbreak of Serratia
marcescens in Tartu University Hospital: a case–control study. BMC
Infectious Diseases 2012 12:281.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Adamson et al. BMC Infectious Diseases 2012, 12:281 Page 6 of 6
http://www.biomedcentral.com/1471-2334/12/281
